AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca’s new cancer drug manufacturing facility to create 800 jobs in Singapore
AstraZeneca’s new cancer drug manufacturing facility to create 800 jobs in Singapore
The facility is set to be operational by 2029.
AstraZeneca plans $2.02b ADC manufacturing facility in Singapore
This is expected to be operational by 2029.
SG acquires AstraZeneca's Evusheld
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
AstraZeneca SG signs MOU with tech partners
The partnerships aim to improve care delivery and patient outcomes.
Commentary
How Singapore businesses can turn automation into shared value
Rethinking authority: A systems thinking perspective on Singaporean workplaces
What matters for Singapore’s AI future is consistency, not brilliance
The AI pilot worked. Now comes the real test
Are Singapore startups’ employee incentive plans still competitive?